• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

runt相关转录因子3促进急性髓系白血病进展。

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression.

作者信息

Zhang Wenwen, Ma Qian, Long Bing, Sun Zhangyi, Liu Lingling, Lin Dongjun, Zhao Minyi

机构信息

Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, ShenZhen, China.

Key Laboratory of Stem Cells and Tissue Engineering, Zhongshan School of Medicine, Sun Yat-sen University, Ministry of Education, Guangzhou, China.

出版信息

Front Oncol. 2021 Oct 12;11:725336. doi: 10.3389/fonc.2021.725336. eCollection 2021.

DOI:10.3389/fonc.2021.725336
PMID:34722267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8549545/
Abstract

Acute myeloid leukemia (AML) is an aggressive hematological malignancy with high relapse/refractory rate. Genetic and epigenetic abnormalities are driving factors for leukemogenesis. RUNX1 and RUNX2 from the Runt-related transcription factor (RUNX) family played important roles in AML pathogenesis. However, the relationship between RUNX3 and AML remains unclear. Here, we found that was a super-enhancer-associated gene and highly expressed in AML cells. The Cancer Genome Atlas (TCGA) database showed high expression of correlated with poor prognosis of AML patients. We observed that knockdown significantly inhibited leukemia progression by inducing DNA damage to enhance apoptosis in murine AML cells. By chromatin immunoprecipitation sequencing (ChIP-seq) analysis, we discovered that RUNX3 in AML cells mainly bound more genes involved in DNA-damage repair and antiapoptosis pathways compared to that in normal bone marrow cells. knockdown obviously inhibited the expression of these genes in AML cells. Overall, we identified as an oncogene overexpressed in AML cells, and knockdown suppressed AML progression by inducing DNA damage and apoptosis.

摘要

急性髓系白血病(AML)是一种侵袭性血液系统恶性肿瘤,复发/难治率高。遗传和表观遗传异常是白血病发生的驱动因素。来自Runt相关转录因子(RUNX)家族的RUNX1和RUNX2在AML发病机制中起重要作用。然而,RUNX3与AML之间的关系仍不清楚。在此,我们发现[基因名称]是一个与超级增强子相关的基因,在AML细胞中高表达。癌症基因组图谱(TCGA)数据库显示,[基因名称]的高表达与AML患者的不良预后相关。我们观察到,[基因名称]敲低通过诱导DNA损伤增强小鼠AML细胞凋亡,显著抑制白血病进展。通过染色质免疫沉淀测序(ChIP-seq)分析,我们发现与正常骨髓细胞相比,AML细胞中的RUNX3主要结合更多参与DNA损伤修复和抗凋亡途径的基因。[基因名称]敲低明显抑制AML细胞中这些基因的表达。总体而言,我们确定[基因名称]为AML细胞中过表达的癌基因,并通过诱导DNA损伤和凋亡抑制AML进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/7900930a488c/fonc-11-725336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/b823cd584cff/fonc-11-725336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/c73b7fc3aabc/fonc-11-725336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/d27fb075303f/fonc-11-725336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/3f7b6ec00279/fonc-11-725336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/7900930a488c/fonc-11-725336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/b823cd584cff/fonc-11-725336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/c73b7fc3aabc/fonc-11-725336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/d27fb075303f/fonc-11-725336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/3f7b6ec00279/fonc-11-725336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e3c/8549545/7900930a488c/fonc-11-725336-g005.jpg

相似文献

1
Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression.runt相关转录因子3促进急性髓系白血病进展。
Front Oncol. 2021 Oct 12;11:725336. doi: 10.3389/fonc.2021.725336. eCollection 2021.
2
Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.RUNX 家族表达与急性髓系白血病的遗传改变和临床结局的显著相关性。
Cancer Biomark. 2020;29(3):387-397. doi: 10.3233/CBM-200016.
3
Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia.人类白血病中 runt 相关转录因子家族的表达及预后分析
Mol Ther Oncolytics. 2018 Dec 18;12:103-111. doi: 10.1016/j.omto.2018.12.008. eCollection 2019 Mar 29.
4
Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions.RUNX1表达适度减弱的急性髓系白血病中白血病发生的矛盾性增强。
Blood Adv. 2017 Aug 8;1(18):1440-1451. doi: 10.1182/bloodadvances.2017007591.
5
Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.急性髓系白血病发生发展过程中 runt 相关转录因子 1 和 3 基因的表达水平
Oncol Lett. 2018 May;15(5):6733-6738. doi: 10.3892/ol.2018.8143. Epub 2018 Mar 1.
6
Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia.急性髓系白血病中t(8;21)和inv(16)融合蛋白对RUNX3/AML2基因的转录抑制作用
Blood. 2008 Oct 15;112(8):3391-402. doi: 10.1182/blood-2008-02-137083. Epub 2008 Jul 28.
7
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.RUNX1(AML-1)和RUNX2(AML-3)与前列腺衍生的Ets因子协同作用,以激活前列腺特异性抗原(PSA)上游调控区域的转录。
J Cell Biochem. 2006 Jan 1;97(1):1-17. doi: 10.1002/jcb.20664.
8
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.胃癌中矮 runt 结构域转录因子 RUNX1、RUNX3 及其辅助因子 CBFB 经常下调。
Int J Cancer. 2005 Jan 10;113(2):221-8. doi: 10.1002/ijc.20551.
9
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.超级增强子谱分析确定了小儿急性髓系白血病中新型关键且可靶向的生存基因 LYL1。
J Exp Clin Cancer Res. 2022 Jul 16;41(1):225. doi: 10.1186/s13046-022-02428-9.
10
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.BRD4 抑制剂 GNE-987 通过靶向急性髓系白血病中的超级增强子相关基因 LYL1 发挥抗癌作用。
J Immunol Res. 2022 Aug 1;2022:7912484. doi: 10.1155/2022/7912484. eCollection 2022.

引用本文的文献

1
Prognostic value of natural killer T cell related genes in acute myeloid leukemia.自然杀伤T细胞相关基因在急性髓系白血病中的预后价值
Cancer Cell Int. 2025 Apr 13;25(1):143. doi: 10.1186/s12935-025-03779-x.
2
CBFA2T3-GLIS2 mediates transcriptional regulation of developmental pathways through a gene regulatory network.CBFA2T3-GLIS2 通过基因调控网络介导发育途径的转录调控。
Nat Commun. 2024 Oct 9;15(1):8747. doi: 10.1038/s41467-024-53158-9.
3
Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics.

本文引用的文献

1
YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.由Runx3-miR-148a-3p轴调控的YBX1促进非小细胞肺癌进展。
Cell Signal. 2021 Sep;85:110049. doi: 10.1016/j.cellsig.2021.110049. Epub 2021 May 31.
2
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.前列腺癌中的超级增强子:转录紊乱与治疗靶点
NPJ Precis Oncol. 2020 Nov 19;4(1):31. doi: 10.1038/s41698-020-00137-0.
3
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.ATR-CHK1 通路作为急性和慢性白血病的治疗靶点。
鉴定正常核型急性髓细胞白血病的新型 DNA 甲基化预后生物标志物。
JCO Clin Cancer Inform. 2024 Jul;8:e2300265. doi: 10.1200/CCI.23.00265.
4
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia.环状 RNA 作为急性髓系白血病新的治疗靶点和工具。
Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):118-136. doi: 10.21873/cgp.20434.
5
Deficiency-Dependent Oncogenicity of Runx3.Runx3 的缺陷依赖性致癌性。
Cells. 2023 Apr 10;12(8):1122. doi: 10.3390/cells12081122.
6
The RUNX Family of Proteins, DNA Repair, and Cancer.RUNX 蛋白家族、DNA 修复与癌症
Cells. 2023 Apr 7;12(8):1106. doi: 10.3390/cells12081106.
7
Runt-related transcription factors in human carcinogenesis: a friend or foe?Runt 相关转录因子在人类肿瘤发生中的作用:是敌是友?
J Cancer Res Clin Oncol. 2023 Sep;149(11):9409-9423. doi: 10.1007/s00432-023-04769-0. Epub 2023 Apr 21.
8
SMGR: a joint statistical method for integrative analysis of single-cell multi-omics data.SMGR:一种用于单细胞多组学数据综合分析的联合统计方法。
NAR Genom Bioinform. 2022 Jul 27;4(3):lqac056. doi: 10.1093/nargab/lqac056. eCollection 2022 Sep.
9
Increased expression of RUNX3 inhibits normal human myeloid development.RUNX3 表达增加抑制正常人类髓系发育。
Leukemia. 2022 Jul;36(7):1769-1780. doi: 10.1038/s41375-022-01577-2. Epub 2022 Apr 30.
Cancer Treat Rev. 2020 Aug;88:102026. doi: 10.1016/j.ctrv.2020.102026. Epub 2020 May 16.
4
How I treat relapsed or refractory AML.我如何治疗复发或难治性 AML。
Blood. 2020 Aug 27;136(9):1023-1032. doi: 10.1182/blood.2019001982.
5
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.RUNX3 通过抑制 RUNX1 的表达驱动骨髓增生异常综合征的转化。
Cancer Res. 2020 Jun 15;80(12):2523-2536. doi: 10.1158/0008-5472.CAN-19-3167. Epub 2020 Apr 27.
6
Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation.致癌性 RUNX3:p53 缺失与 MYC 失调之间的联系。
Mol Cells. 2020 Feb 29;43(2):176-181. doi: 10.14348/molcells.2019.0285.
7
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.超级增强子:血液系统恶性肿瘤中的关键作用和治疗靶点。
J Hematol Oncol. 2019 Jul 16;12(1):77. doi: 10.1186/s13045-019-0757-y.
8
RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer.RUNX3通过抑制结直肠癌中的Hedgehog信号通路来抑制转移和干性。
Cell Death Differ. 2020 Feb;27(2):676-694. doi: 10.1038/s41418-019-0379-5. Epub 2019 Jul 5.
9
Genetic and epigenetic determinants of AML pathogenesis.AML 发病机制的遗传和表观遗传决定因素。
Semin Hematol. 2019 Apr;56(2):84-89. doi: 10.1053/j.seminhematol.2018.08.001. Epub 2018 Aug 22.
10
IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.IKZF2 驱动白血病干细胞自我更新并抑制髓系分化。
Cell Stem Cell. 2019 Jan 3;24(1):153-165.e7. doi: 10.1016/j.stem.2018.10.016. Epub 2018 Nov 21.